"Sezary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).
Descriptor ID |
D012751
|
MeSH Number(s) |
C04.557.386.480.750.800.775 C15.604.515.569.480.750.800.775 C15.604.515.841 C20.683.515.761.480.750.800.775 C20.683.515.920
|
Concept/Terms |
Sezary Syndrome- Sezary Syndrome
- Syndrome, Sezary
- Sezary's Lymphoma
- Lymphoma, Sezary's
- Sezary Lymphoma
- Sezarys Lymphoma
- Erythroderma, Sezary
- Sezary Erythroderma
|
Below are MeSH descriptors whose meaning is more general than "Sezary Syndrome".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
- Sezary Syndrome [C04.557.386.480.750.800.775]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Sezary Syndrome [C15.604.515.569.480.750.800.775]
- Sezary Syndrome [C15.604.515.841]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
- Sezary Syndrome [C20.683.515.761.480.750.800.775]
- Sezary Syndrome [C20.683.515.920]
Below are MeSH descriptors whose meaning is more specific than "Sezary Syndrome".
This graph shows the total number of publications written about "Sezary Syndrome" by people in this website by year, and whether "Sezary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2017 | 5 | 1 | 6 |
2018 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sezary Syndrome" by people in Profiles.
-
COVID-19 infection in patients with Sézary syndrome: Report of two cases. Dermatol Ther. 2020 11; 33(6):e14042.
-
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Aug; 83(2):703-704.
-
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome. Leuk Lymphoma. 2019 08; 60(8):1899-1907.
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2018 09; 19(9):1192-1204.
-
Developments in the understanding of blood involvement and stage in mycosis fungoides/Sezary syndrome. Eur J Cancer. 2018 09; 101:278-280.
-
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. Eur J Cancer. 2018 04; 93:47-56.
-
KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting. Blood. 2017 12 28; 130(26):2900-2902.
-
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. AIDS. 2017 08 24; 31(13):1839-1845.
-
Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity. Blood. 2017 09 21; 130(12):1468-1471.
-
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer. 2017 05; 77:57-74.